Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - A meta-analysis.

Metformin is the first-choice drug for patients with Type 2 diabetes, and this therapy is characterized by being weight neutral. However, in the elderly an additional unintentional weight loss could be considered as an adverse effect of the treatment.We aimed to perform a meta-analysis of placebo-co...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Szekeres-Solymár Margit
Ivic Ivan
Pótó László
Hegyi Péter
Garami András
Hartmann Petra
Pétervári Erika
Czopf László
Alizadeh Hussain
Gyöngyi Zoltán
Sarlós Patrícia
Simon Mária
Mátrai Péter
Bérczi Bálint
Balaskó Márta
Dokumentumtípus: Cikk
Megjelent: 2018
Sorozat:PLOS ONE 13 No. 11
doi:10.1371/journal.pone.0207947

mtmt:30330535
Online Access:http://publicatio.bibl.u-szeged.hu/14748

Hasonló tételek